EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Leptin and leptin receptor in patients with chronic hepatitis C Effect of interferon/ribavirin combination therapy


Gastroenterology 122(4 Suppl 1): A 644, April
Leptin and leptin receptor in patients with chronic hepatitis C Effect of interferon/ribavirin combination therapy


Accession: 035216334



Related references

Mutagenic effect of ribavirin in ns5a and ns5b regions and response to interferon/ribavirin combination therapy in patients with chronic hepatitis c. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No T1262, 2003

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine. Wiener Klinische Wochenschrift 116(15-16): 530-535, 2004

Treatment with amantadine + ribavirin + interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A143, April, 2000

Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin. Journal of Gastroenterology and Hepatology 22(11): 1894-1897, 2007

Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers. Hepatology 36(4 Part 2): 358A, October, 2002

The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. Journal of Hepatology 23 Suppl 2: 8-12, 1995

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hepatology 38(1): 66-74, 2003

Pegylated interferon alfa 2b plus ribavirin in patients with chronic hepatitis c a trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers final results. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 504, 2003

Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C. Hepatology Research 32(2): 101-106, 2005

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C. Journal of Gastroenterology 39(11): 1090-1094, 2004